-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Coagulation Factor XII (F12) Haploinsufficiency Is Protective Against Venous Thromboembolism

Program: Scientific Symposia
Session: Special Symposium on the Basic Science of Hemostasis and Thrombosis
Hematology Disease Topics & Pathways:
Research, Bleeding and Clotting, Adult, Epidemiology, Clinical Research, Bioinformatics, Thromboembolism, Diseases, Registries, Technology and Procedures, Study Population, Human, Omics technologies
Monday, December 9, 2024, 4:30 PM-6:00 PM

Amelia K Haj, MD, PhD

Department of Pathology, Massachusetts General Hospital, Cambridge, MA; The Broad Institute of MIT and Harvard, Cambridge, MA; Harvard Medical School, Boston, MA

Disclosures: No relevant conflicts of interest to declare.

<< Previous Presentation | Next Presentation